ALVOGEN
6 articole · RSS
Zentiva Group Buys Alvogen’s Operations In CEE, Including Labormed Plant In Romania
Zentiva Group, also present on the Romanian market, has announced the acquisition of the operations in Central and Eastern Europe of pharmaceuticals company Alvogen, for an undisclosed amount.
Advent Sold Labormed For $33M, 20% Of Acquisition Price
Investment fund Advent sold Romanian generic drug producer Labormed last year to U.S. pharmaceutical company Alvogen for $33 million (EUR24 million), less than 20% of the acquisition price p...
Alvogen Aims For 15% Growth In 2014
Alvogen and Labormed Pharma, which the former bought last December, will post 265 million lei (EUR60 million) revenue in 2013, says Laurentiu Scheusan, Alvogen’s executive vice-president in...
New Owner Of Labormed Wants Less Reliance On Romanian Market
The priority of the new owner of pharmaceutical producer Labormed, Alvogen, is to make the company less reliant on the Romanian market, says Laurentiu Scheusan, Alvogen’s executive vice pres...
U.S. Alvogen Acquires Generic Drug Maker Labormed
U.S. pharmaceutical company Alvogen on Thursday said it acquired Romanian generic drug producer Labormed in December 2012 from private equity firm Advent International.
Negotiations On Labormed’s Takeover By U.S. Alvogen Almost Finished
Negotiations on the takeover of Romanian drug producer Labormed by U.S. pharmaceutical company Alvogen from investment fund Advent are almost finished and a decision on the matter will be pr...